Project Grant S10GM164750
- The National Institute of General Medical Sciences awarded $249,961 to the University of Puerto Rico Medical Sciences Campus on August 5, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to acquire an Agilent Seahorse XF Pro Analyzer for real-time assessment of mitochondrial respiration and cellular bioenergetics. The instrument will enable high-throughput metabolic profiling of cells and isolated mitochondria, supporting multiple NIH- and NSF-funded projects...
- The National Institute of General Medical Sciences, part of the Department of Health and Human Services, awarded the University of Alaska Fairbanks $249,966 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to acquire analytical chemistry instrumentation. The award funds the acquisition of a Thermo Scientific TSQ Quantis Plus triple quadrupole mass spectrometer coupled with a Vanquish Flex ultra-high-pressure liquid chromatograph (UHPLC), capable...
- Auburn University Montgomery (AUM) received a $249,818 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2026. The award supports the acquisition of a Seahorse XFE24 Extracellular Flux Analyzer, a specialized instrument designed to measure cellular metabolic parameters including glycolysis and mitochondrial oxidative phosphorylation. This...
- The National Institute of General Medical Sciences awarded the University of Arkansas $401,254 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support a five-year project investigating the genetic basis of post-transcriptional regulation of cellular stress defenses. The project applies quantitative and high-throughput genetic approaches using budding yeast (Saccharomyces cerevisiae) to understand how natural genetic variation influences the...
- The National Institute of General Medical Sciences awarded the University of North Texas $249,200 on July 1, 2026, through the Biomedical Research and Research Training program (CFDA 93.859) to acquire a Fujifilm VisualSonics VEVO F2 LT high-resolution ultrasound imaging system for small-animal research. The system will establish centralized ultrasound imaging capabilities at the university's vivarium, enabling real-time, non-invasive in vivo cardiac and tumor imaging across small-animal...
- The National Institute of General Medical Sciences awarded East Tennessee State University $250,000 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to acquire a liquid-chromatography tandem mass spectrometry (LC-MS/MS) system. The instrument will support biomedical research and educational initiatives across the university's Academic Health Science Center, primarily serving researchers and students in the Colleges of Medicine and Pharmacy, with access...
- The National Institute of General Medical Sciences awarded the University of Louisiana at Monroe $177,721 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to acquire a Biacore X100 surface plasmon resonance (SPR) instrument for biomedical research and education. The instrument will enable real-time, label-free analysis of biomolecular interactions, including kinetic and affinity measurements for proteins, nucleic acids, and small molecules. ULM will...
- The National Institute of General Medical Sciences awarded Arizona State University $2,081,661 on August 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop plasmonic and evanescent scattering microscopy technologies for label-free functional imaging of single molecular and cellular activities. The recipient will advance optical detection methods that measure intrinsic molecular and cellular optical properties without fluorescent or radioactive...
- The National Institute of General Medical Sciences awarded the University of Oregon $398,464 on March 6, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop responsive and targeted modulation of reactive sulfur species. Over the five-year period of performance ending December 31, 2030, the recipient will develop innovative chemical approaches to manipulate and understand hydrogen sulfide (H2S) and reactive sulfur species (RSS) in biological systems. The...
- The National Institute of General Medical Sciences awarded the University of North Carolina at Pembroke $208,666 on July 2, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to acquire a thermogravimetric analyzer with evolved gas analysis capabilities for materials research and STEM education. The instrument will support three faculty-led research initiatives focused on biomass pyrolysis, plastics recycling, and polymeric adsorbents for environmental remediation,...
The National Institute of General Medical Sciences awarded the University of Arkansas–Fort Smith $132,867 on September 4, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to procure a Sable Systems respirometry system for expanding research and educational capacity in biomedical sciences. The respirometry system measures metabolic rates—oxygen consumption, carbon dioxide production, methane, and water flux—across organisms ranging from fruit flies to humans, plants, fungal cultures, and water samples. The instrumentation enables investigations into the physiological impacts of psychological stress, pollution, and behavior, including measurements of resting and basal metabolic rates, exercise metabolism, respiratory quotient, specific dynamic action, gastrointestinal fermentation activity, respiratory water loss, and whole-body water loss. UAFS, a primarily undergraduate institution with approximately 5,500 students, serves a diverse regional population with more than 50 percent Pell Grant eligibility and more than 50 percent first-generation college attendees. The university experienced rapid growth in academic programs following its 2002 transition to a four-year university but has not proportionally expanded research infrastructure and equipment capacity, hampering student access to research experiences. The state-of-the-art instrumentation will provide students, many pursuing their first biomedical careers, access to equipment comparable to that available at established research institutions. Performance of work occurs in Fort Smith, Arkansas. The period of performance runs through August 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $132.9k | 9/3/26 |